Sometimes people react strangly and irrationaly to the news. It i soften bacaus we rely on what others tell us, though we all have our own experiences. So, if we think the benefits of a “thing” outweigh the costs, we are likely to buy or engage in the activity. But if we think we could lose out, we avoid or reject the “thing”. This is a problem because, if you avoid something, you never give yourself the chance to find out whether you actually lose. One morething, marketing relies in most cases on optimistic claims and can leave often you disappointed. Thus you are able to update your expectations. Except, of course, not everyone is this rational. We all have our prejudices. Trust is another strongest factor – we tend to accept advice from people who confirm we are right rather than from those who might challenge our beliefs.
As we hear an “expert” telling us something, we subcontiously will act depending on the sympathy and trust to his person, his politically, economically or other reputation, or just becaus of his appearance … Here, the advice of this “expert” might seem accurate and will make no difference timely .
The main thing about a risk is uncertainty. It is something you can’t measure easily and the problem of how we react depends on how quickly the risk might come true. Like ther’s no use of telling a smoker there’s a risk of cancer ater a period of twenty years. That’ much a pleasure now and the mirrage you will can do amything about it before he really faces the risk.
The main subject of this artcile is interested for people who need effective pain relief. It concerns the latest changes of Tramadol labels, announced by the FDA. The doctors were also advised a change in the way they give prescriptions. The trouble aroused because two or three people who were taking opioid painkillers have died. It comes down to overdoses – a tiny percentage of cases. It seems one or two people who were emotionally disturbed and depressed died when they took too much of the drug. The FDA tends to work on precautionary measures, if such cases repeat and only if tens were dying, they would take the drug off the market. Doctors are counselled to carefully discuss Tramadol usage if their patients are also taking tranquilizers or an antidepressant.
On efact would make this advice more credible. The FDA seem to be less in the pocket of Big Pharma than under the last Administration. The reality of the warning, however, seems to apply only to an insignificant number of people among all Tramadol patients. Of course we don’t suggest you ignore an FDA announcement, just take the facts into consideration. If Tramadol benefits are indispensable to you, and those risks are limited by special severe conditions as depression, will yourefuse your life-saving medication? In this case the new label shouldn’t be a concern to you.
Random Posts
Comments Off